Water → (3S)-2-methyl-4-{4-[3-(3-methylpiperidin-1-yl)propoxy]phenyl}pyridine 1-oxide
Reaction equation
[OH:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][N+:11]([O-:14])=[C:10]([CH3:15])[CH:9]=2)=[CH:4][CH:3]=1.C(=O)([O-])[O-].[K+].[K+].Cl.CS(O[CH2:28][CH2:29][CH2:30][N:31]1[CH2:36][CH2:35][CH2:34][C@H:33]([CH3:37])[CH2:32]1)(=O)=O.O>CN(C)C=O>[CH3:15][C:10]1[CH:9]=[C:8]([C:5]2[CH:4]=[CH:3][C:2]([O:1][CH2:28][CH2:29][CH2:30][N:31]3[CH2:36][CH2:35][CH2:34][C@H:33]([CH3:37])[CH2:32]3)=[CH:7][CH:6]=2)[CH:13]=[CH:12][N+:11]=1[O-:14]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A A mixture of 4-(4-hydroxyphenyl)-2-methylpyridine 1-oxide (55 mg), potassium carbonate (187 mg) and (3S)-1-(3-methanesulfonyloxypropyl)-3-methylpiperidine hydrochloride in N,N-dimethylformamide (3 mL) is heated at a temperature close to 65° C. overnight and cooled back to room temperature. Water (5 mL) is added; the solution is washed with methylcyclohexane (twice 10 mL) and concentrated under reduced pressure. The residue is purified by chromatography over silica gel (eluent dichloromethane/methanol from 95/5 to 80/20). Fraction containing the expected product are pooled and concentrated under reduced pressure. The crude base is diluted in ethanol, oxalic acid (7 mg) is added and solvent is removed under reduced pressure to give 32 mg of (3S)-2-methyl-4-{4-[3-(3-methylpiperidin-1-yl)propoxy]phenyl}pyridine 1-oxide, oxalate as a brown crystalline material.
Workup
- temperatureis heated at a temperature
- customclose to 65° C. overnight
- washthe solution is washed with methylcyclohexane (twice 10 mL)
- concentrationconcentrated under reduced pressure
- customThe residue is purified by chromatography over silica gel (eluent dichloromethane/methanol from 95/5 to 80/20)
- additionFraction containing the expected product
- concentrationconcentrated under reduced pressure
- additionThe crude base is diluted in ethanol
- additionoxalic acid (7 mg) is added
- customsolvent is removed under reduced pressure
Sources & evidence
- ORD record
- ord-4c40da2760804c0f8eb8014fbb2767e9
- Source dataset
- uspto-grants-2011_12
- Patent number
- US08076329B2
Reaction notes
Loading…